Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease

Background: Renin-angiotensin system inhibitor and calcium channel blocker (CCB) are widely used in controlling blood pressure (BP) in patients with chronic kidney disease (CKD). We carried out a meta-analysis to compare the renoprotective effect of the combination of angiotensin-converting enzyme i...

Full description

Bibliographic Details
Published in:	Chinese Medical Journal
Main Authors:	Rong-Shuang Huang, Yi-Ming Cheng, Xiao-Xi Zeng, Sehee Kim, Ping Fu
Format:	Article
Language:	English
Published:	Wolters Kluwer 2016-01-01
Subjects:	Calcium Channel Blocker; Chronic Kidney Disease; Hypertension; Renin-angiotensin System Inhibitor; Renoprotection; Therapy
Online Access:	http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=5;spage=562;epage=569;aulast=Huang

Similar Items

Calcium Channel Blocker Versus Renin–Angiotensin System Inhibitor in Risk of Kidney Cancer Among Patients With Hypertension: A Propensity Score‐Matched Cohort Study
by: Minji Jung, et al.
Published: (2024-11-01)

Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension
by: Jie Wei, et al.
Published: (2019-12-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
by: Kamryn E. Jones, et al.
Published: (2024-06-01)

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
by: Siragy H
Published: (2011-05-01)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
by: Huijin Lee, et al.
Published: (2024-10-01)

Impact of renin-angiotensin system inhibitors and beta-blockers on dental implant stability
by: Babak Saravi, et al.
Published: (2021-04-01)

The renin-angiotensin system and its blockers
by: Igić Rajko, et al.
Published: (2014-01-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
by: Jordan Loader, et al.
Published: (2022-06-01)

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry
by: Fabio Angeli, et al.
Published: (2022-01-01)

Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
by: Nestor Vazquez-Agra, et al.
Published: (2023-03-01)

Synthesis of Novel 1,4- Dihydropyridine Derivatives Bearing Biphenyl-2'-Tetrazole Substitution as Potential Dual Angiotensin II Receptors and Calcium Channel Blockers
by: Javid Shahbazi Mojarrad, et al.
Published: (2011-06-01)

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
by: Juan Meng, et al.
Published: (2020-01-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

Urinary angiotensinogen as a surrogate marker predicting the antiproteinuric effects of angiotensin receptor blockers in patients with overt proteinuria: a multicenter prospective study
by: Junseok Jeon, et al.
Published: (2020-05-01)

Renal Outcomes With Renin-Angiotensin System Blockers After Unilateral Nephrectomy
by: Sehun Lee, et al.
Published: (2025-01-01)

The Effects of Different Calcium Channel Blockers on Aldosterone-Producing Adenoma Cells
by: Fen Wang, et al.
Published: (2020-04-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy
by: Lin Zhang, et al.
Published: (2017-10-01)

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH STABLE ANGINA AND ARTERIAL HYPERTENSION
by: Paplauskaya E. E.
Published: (2020-05-01)

Renin Is Essential for Angiotensin II Formation in the Brain
by: André F. Rodrigues, et al.
Published: (2024-11-01)

Angiotensin Converting Enzyme Inhibitor Has a Protective Effect on Decompression Sickness in Rats
by: Aleksandra Mazur, et al.
Published: (2018-03-01)

Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine
by: Keisuke Okamura, et al.
Published: (2018-02-01)

Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
by: R de O. Caminhotto, et al.
Published: (2016-07-01)

The dual blockade of the renin-angiotensin system in Internal Medicine: after ONTARGET trial
by: F. Rondoni, et al.
Published: (2013-05-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
by: Chinonyerem O. Iheanacho, et al.
Published: (2024-04-01)

A Modern View on the Treatment for Acute Calcium Channel Blocker Poisoning
by: A. Yu. Simonova, et al.
Published: (2024-09-01)

Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial
by: Gyu Chul Oh, et al.
Published: (2017-09-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
by: Hany A Al-Hussaniy, et al.
Published: (2023-01-01)

The Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Advanced-Stage Diabetic Kidney Disease Taking Renin-Angiotensin System Blockers
by: Hirai K, et al.
Published: (2020-01-01)

Impact of Renin‐Angiotensin System Inhibitors on Long‐Term Clinical Outcomes of Patients With Coronary Artery Spasm
by: Byoung Geol Choi, et al.
Published: (2016-07-01)

Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort
by: Sungji Moon, et al.
Published: (2020-11-01)

The Impact of Beta-Blockers and Renin-Angiotensin-Aldosterone System Inhibitors on the Prognosis of Atrial Fibrillation Patients with Chronic Obstructive Pulmonary Disease: A Nation-Wide Registry Study
by: Liang H, et al.
Published: (2025-03-01)

The clinical relevance of local renin angiotensin systems
by: Duncan John Campbell
Published: (2014-07-01)

Systematic Review and Meta-Analysis of Renin–Angiotensin–Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease
by: Katsunori Yanai, et al.
Published: (2021-07-01)

Preoperative long-term use of renin-angiotensin-aldosterone system blockers increases the risk of acute kidney injury after coronary artery bypass grafting
by: Xiaokang Xu, et al.
Published: (2025-12-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)